Atlanta Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$48.8M Buy
149,879
+8,666
+6% +$3.18M 0.22% 109
2022
Q2
$49.5M Buy
+141,213
New +$57.6M 0.21% 115
2017
Q3
Sell
-27,541
Closed -$4.45M 157
2017
Q2
$4.45M Sell
27,541
-1,480,025
-98% -$240M 0.03% 144
2017
Q1
$233M Sell
1,507,566
-712,233
-32% -$98.2M 1.43% 24
2016
Q4
$260M Sell
2,219,799
-11,512
-0.5% -$1.31M 1.66% 15
2016
Q3
$252M Sell
2,231,311
-274,206
-11% -$28.9M 1.67% 16
2016
Q2
$233M Buy
2,505,517
+115,283
+5% +$9.9M 1.55% 21
2016
Q1
$187M Sell
2,390,234
-9,300
-0.4% -$670K 1.33% 23
2015
Q4
$175M Buy
2,399,534
+284,076
+13% +$20.3M 1.28% 23
2015
Q3
$157M Buy
2,115,458
+249,729
+13% +$17.9M 1.18% 23
2015
Q2
$120M Buy
1,865,729
+59,321
+3% +$4.11M 0.81% 46
2015
Q1
$140M Sell
1,806,408
-10,546
-0.6% -$821K 0.95% 36
2014
Q4
$135M Sell
1,816,954
-16,544
-0.9% -$1.16M 0.93% 43
2014
Q3
$108M Sell
1,833,498
-10,646
-0.6% -$673K 0.78% 52
2014
Q2
$123M Buy
1,844,144
+1,984
+0.1% +$126K 0.84% 44
2014
Q1
$112M Buy
1,842,160
+136,524
+8% +$8.13M 0.77% 51
2013
Q4
$90.7M Buy
1,705,636
+336,684
+25% +$17.7M 0.59% 70
2013
Q3
$68.2M Sell
1,368,952
-6,076
-0.4% -$292K 0.48% 80
2013
Q2
$61.7M Buy
+1,375,028
New +$60.1M 0.47% 83

Other funds holding IDXX

Atlanta Capital Management's IDXX Position: Q3 2022 in Review

Atlanta Capital Management increased its Idexx Laboratories (IDXX) stake by 6.1% in Q3 2022, buying an estimated $3.18M and bringing the position to 149,879 shares worth $48.8M. The position accounts for 0.22% of the portfolio, ranked #109.

Atlanta Capital Management first reported a position in IDXX in Q2 2013 and has held it in 19 quarters since. The position peaked at $260M in Q4 2016. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Atlanta Capital Management held 149,879 shares of Idexx Laboratories worth $48.8M as of Q3 2022.
  • Atlanta Capital Management bought 8,666 Idexx Laboratories shares in Q3 2022, an estimated $3.18M.
  • Idexx Laboratories made up 0.22% of Atlanta Capital Management's portfolio in Q3 2022, its #109 holding.
  • Atlanta Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 19 quarters since.
  • Atlanta Capital Management's Idexx Laboratories position peaked at $260M in Q4 2016.
  • 925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.